from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2174/mptA

LFCtreatmentdescriptionclass of inhibitor

-0.037

Amikacinug/mL Amikacintranslation

-1.301

Cap5-10ug/mL Capreomycintranslation

-1.264

Rox10-50 ug/mL Roxithromycintranslation

-0.361

SM2-5 ug/mL Streptomycintranslation

0.103

Tet5-10 ug/mL Tetracyclinetranslation

0.214

Rif0.2-5ug/mL Rifampicintranscription

-0.868

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.854

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.485

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.532

CPZ10-50 ug/mL Chlorpromazinerespiration

0.967

Clofazimine10-13 ug/mL Clofaziminerespiration

0.602

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.006

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.307

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.155

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.480

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.451

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.660

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.193

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.070

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.525

KCN5-20 ug/mL Potassium cyaniderespiration

-0.591

NaN30.2-2 mM Sodium aziderespiration

1.260

Nigericin50 uM Nigericinrespiration

0.346

TRC10-150 ug/mL Triclosanrespiration

-0.635

TRZ10-25 ug/mL Thioridazinerespiration

-3.238

Valinomycin0.5-10 uM Valinomycinrespiration

-0.203

ZnSO42 mM ZnSO4respiration

-0.185

menadione6-10 ug/mL Menadionerespiration

0.791

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.033

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.277

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.041

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.118

NRP_1Non-replicating persistence stage 1dosRassociated

-0.511

Amp0.2mg/mL AmpicillincellWall

0.807

Cephalexin20-100 ug/mL CephalexincellWall

-0.046

Cerulenin0.32-5 ug/mL CerulenincellWall

0.877

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.374

EMB10-20 ug/mL EthambutolcellWall

0.372

Eta12-40 ug/mL EthionamidecellWall

-0.334

INH0.2-0.4 ug/mL IsoniazidcellWall

0.116

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.291

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.008

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.172

BZA0.12 mg/mL BenzamidearomaticAmides

0.077

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.326

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.099

H2O24 mM hydrogen peroxideDNAdamaging

-0.385

Levo10 ug/mL LevofloxacinDNAdamaging

-0.107

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.675

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.146

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.565

UVUV-irradiationDNAdamaging

0.045

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.105

Antimycin12.5-50 ug/mL Antimycin A?

0.188

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.389

PA_110-50 ug/mL Antitubercular compound PA-1?

0.136

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.025

PA8240.2-2 ug/mL PA-824?

-0.287

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.456

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.802

Verapamil50 uM Verapamil?

0.399

mercaptoethanol2 mM 2-Mercaptoethanol?

0.609

methoxatin10-20 ug/mL Methoxatin?